We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
+23.08%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
10 Year Est. Return
AUM
$150M
AUM Growth
+$23.9M
Cap. Flow
+$727K
Cap. Flow %
0.49%
Top 10 Hldgs %
54.03%
Holding
111
New
10
Increased
40
Reduced
43
Closed
3

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$1.15M
2
ANET icon
Arista Networks
ANET
+$241K
3
SNOW icon
Snowflake
SNOW
+$241K
4
WMT icon
Walmart Inc
WMT
+$201K
5
SYK icon
Stryker
SYK
+$196K

Sector Composition

Rank Sector Weight
1 Technology 62.98%
2 Healthcare 9.81%
3 Financials 7.08%
4 Industrials 5.53%
5 Communication Services 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LULU icon
101
lululemon athletica
LULU
$14B
$214K 0.14%
900
-125
-12% -$34.4K
MPC icon
102
Marathon Petroleum
MPC
$91.3B
$209K 0.14%
1,259
-195
-13% -$29.2K
GLW icon
103
Corning
GLW
$137B
$207K 0.14%
+3,940
New +$184K
SYK icon
104
Stryker
SYK
$129B
$207K 0.14%
+523
New +$196K
WMT icon
105
Walmart Inc
WMT
$888B
$206K 0.14%
+2,111
New +$201K
ADP icon
106
Automatic Data Processing
ADP
$108B
$206K 0.14%
666
BA icon
107
Boeing
BA
$187B
$203K 0.14%
+968
New +$183K
EW icon
108
Edwards Lifesciences
EW
$51.6B
$202K 0.14%
+2,585
New +$193K
EPD icon
109
Enterprise Products Partners
EPD
$82.5B
-6,581
Closed -$225K
REGN icon
110
Regeneron Pharmaceuticals
REGN
$78.3B
-330
Closed -$209K
UNH icon
111
UnitedHealth
UNH
$370B
-1,437
Closed -$752K

Similar funds

KRS Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, KRS Capital Management held 111 positions worth $150M, up 19% from $126M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

KRS Capital Management's Q2 2025 filing shows 10 new, 40 increased, 43 reduced and 3 closed positions. Its largest new stake was Lam Research: 14,498 shares worth $1.41M. The largest sale was UnitedHealth, an estimated $752K.

By sector, the portfolio is most concentrated in Technology at 63% of assets, up from 58% a quarter earlier, followed by Healthcare and Financials.

  • KRS Capital Management's largest Q2 2025 buy was Lam Research: 14,498 shares worth $1.41M.
  • KRS Capital Management added most to Oneok in Q2 2025, an estimated $184K increase.
  • KRS Capital Management's biggest Q2 2025 reduction was Advanced Micro Devices, cutting an estimated $446K.
  • KRS Capital Management fully exited UnitedHealth in Q2 2025, selling an estimated $752K.
  • KRS Capital Management's ten largest holdings make up 54% of its $150M portfolio in Q2 2025.
  • KRS Capital Management opened 10 new positions and closed 3 in Q2 2025.
  • KRS Capital Management's portfolio value rose 19% quarter-over-quarter to $150M.

Based on KRS Capital Management's 13F filing for Q2 2025, filed 24 Jul 2025.